1. Correlations of the breast cancer hypoxia metagene with Ki67 and the proliferation metagene.
Correlations of the breast cancer hypoxia metagene with Ki67 and the proliferation metagene. A, hypoxia metagene expression versus Ki67 expression prior to AI treatment. B, hypoxia metagene expression versus proliferation metagene expression prior to AI treatment. C, hypoxia metagene expression versus Ki67 expression at 2 weeks posttreatment (blue points) and at 16-week posttreatment (red points). D, hypoxia metagene expression versus proliferation metagene expression at 2 weeks posttreatment (blue points) and at 16 weeks posttreatment (red points).
Zara Ghazoui et al. Clin Cancer Res 2011;17:
©2011 by American Association for Cancer Research